News

Signature of Memorandum of Understanding with FDA !
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.

Visit to the FDA
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.

Avicenna Alliance in one year
Avicenna Alliance is proud to present its brochure showing the main achievements of the Alliance in one year.

FDA singles out Avicenna Alliance to form part of EU delegation
Next week of 15 May 2017-18 May, the Avicenna Alliance will have a busy week ahead. The FDA has invited the Avicenna Alliance to visit the FDA for high level talks on the future of regulation of in silico medicine will take place on 15 May. The full invitation letter can be found below. Avicenna Alliance welcomes this collaboration with the FDA and looks forward to the next steps towards effective regulation of the in silico market.

Promeditec joins Avicenna Alliance!
Avicenna Alliance is proud to announce the newest addition to its list of members: Promeditec.

EFGCP becomes an institutional member of the Avicenna Alliance!
This month, Avicenna Alliance is delighted to announce that the European Forum For Good Clinical Practice (EFGCP) officially joined the Avicenna Alliance as an institutional member.